Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022

Saba A Qasmieh; McKaylee M Robertson; Chloe A Teasdale; Sarah G Kulkarni; Denis Nash

doi:10.1093/cid/ciac644

Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022

Clin Infect Dis. 2023 Feb 8;76(3):e499-e502. doi: 10.1093/cid/ciac644.

Authors

Saba A Qasmieh^{1

2}, McKaylee M Robertson^{1

2}, Chloe A Teasdale^{1

2}, Sarah G Kulkarni¹, Denis Nash^{1

2}

Affiliations

¹ Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, New York, USA.
² Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, New York, USA.

Abstract

In a population-based survey of adults in New York City, we assessed positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (including via exclusive at-home testing) and possible cases among untested respondents. An estimated 27.4% (95% confidence interval [CI]: 22.8%-32.0%) or 1.8 million adults (95% CI: 1.6-2.1 million) had SARS-CoV-2 infection between 1 January and 16 March 2022.

Keywords: at-home rapid SARS-CoV-2 tests; population-based surveys; prevalence; surveillance.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
COVID-19* / epidemiology
Humans
New York City / epidemiology
Prevalence
SARS-CoV-2*